- Order Reprints
- Print Article
Summary
Summary
U.S
Europe
Asia
FX
Rates
Futures
ETFs
Crypto
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
https://www.barrons.com/articles/kenvue-jnj-stock-exchange-offer-e85c3c90
It’s crunchtime for investors in Johnson & Johnson who need to make a decision soon about whether to participate in J&J’s $40 billion exchange offer for shares in Kenvue, the consumer health business that J&J took public in May.
An error has occurred, please try again later.
Thank you
This article has been sent to